Olema Pharmaceuticals Inc

OLMA NASDAQ Healthcare & Biotech United States US68062P1066
9.78 $
4.96 %

Olema Pharmaceuticals Inc specializes in the development of targeted therapies for the treatment of hormone-dependent breast cancer.